New pyrazolopyridmiin-2-yl derivatives are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).
新的
吡唑吡啶-2-基衍
生物被披露;以及它们的制备方法,包含它们的药物组合物以及它们作为Janus激酶(JAK)
抑制剂在治疗中的用途。